EcoDrugPlus

Tubulin Beta 1 Class Vi

Ensembl ID : ENSBGRG00000024823
Gene Symbol: TUBB1
1 Cross references
186 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSBGRG00000008862
Gene Symbol: TUBB2A
1 Cross references
228 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSBGRG00000024423
Gene Symbol: TUBB3
1 Cross references
154 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSBGRG00000026030
Gene Symbol: TUBB4A
1 Cross references
89 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSBGRG00000008599
Gene Symbol: TUBB
1 Cross references
251 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSBGRG00000003025
Gene Symbol: TYK2
1 Cross references
197 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSBGRG00000010328
Gene Symbol: TIE1
1 Cross references
205 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSBGRG00000006239
Gene Symbol: UTS2R
1 Cross references
92 Possible Orthologues:

Utrophin

Ensembl ID : ENSBGRG00000020833
Gene Symbol: UTRN
1 Cross references
268 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSBGRG00000010227
Gene Symbol: VEGFA
1 Cross references
254 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSBGRG00000024120
Gene Symbol: VDR
1 Cross references
466 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSBGRG00000023947
Gene Symbol: VKORC1
1 Cross references
190 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).